Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR)

Q: What does CUSIP 471871202 represent in this 13F holders report?

CUSIP 471871202 is the security identifier for JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share in Q1 2026?

57 institutional investors reported JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 471871202

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Voting Common Stock, par value $0.0001 per share
Total 13F shares: 15,813,140
Total 13F value: $13,860,993
Share change: -3,407,594
Put/Call ratio: 22%
SEC-reported price per share: $0.88
Number of holders: 57
Value change: -$7,106,029
Number of buys: 24
Number of sells: 21
Shares outstanding: 33,902,298

Security key

471871202

Report period

Q1 2026

Institutions

Top holders

JSPR full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Jasper Therapeutics, Inc. SEC filings Jasper Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 471871202

Newer quarter: Q2 2026

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

T. Rowe Price Investment ...

Disclosed value leader

Velan Capital Investment ...

Comparable rows

15/15

Latest evidence

31 Mar 2026

13D/G 13F 3/4/5 Lead comparable stake: 7.1% 13D/G row: T. Rowe Price Investment Management, Inc. Showing 1-6 of 15 holder rows.

Quick read

T. Rowe Price Investment Management, Inc. leads the comparable SEC ownership view at 7.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens T. Rowe Price Investment Management, Inc.'s linked filing trail.

Comparable ownership Top 5

T. Rowe Price Investment Manageme... 7.1%

ACORN BIOVENTURES, L.P. 5.3%

MORGAN STANLEY 4.8%

KINGDON CAPITAL MANAGEMENT, L.L.C. 4.7%

Carlyle Group Inc. 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
T. Rowe Price Investment Management, Inc.	13D/G 13F Company 13D/G 13F	7.1%	$4,897,117 2,057,612 shares	$0	30 Sep 2025
ACORN BIOVENTURES, L.P.	13D/G Anders Hove 13D/G	5.3%	$2,660,821 1,486,492 shares	-$537,000	23 Jan 2026
MORGAN STANLEY	13F 13D/G Company 13F 13D/G	4.8% from 13D/G	$3,604,707 1,969,785 shares	—	31 Dec 2025
KINGDON CAPITAL MANAGEMENT, L.L.C.	13D/G 13D/G	4.7%	$3,153,131 1,324,845 shares	+$1,332,431	30 Sep 2025
Carlyle Group Inc.	3/4/5 13D/G 13F Former 10% Owner · The Carlyle Group Inc. · Company 3/4/5 13D/G 13F	3.8% from 13D/G	$13,807,148 1,066,189 shares	—	08 Feb 2024
Qiming U.S. Healthcare Fund II, L.P.	3/4/5 13D/G 10%+ Owner 3/4/5 13D/G	3.3% from 13D/G	$5,525,844 8,519,648 shares	—	27 Jan 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

15,813,140

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend